(Q42640493)

English

Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extension

scientific article published on January 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extension (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Parkinson's disease dementia

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

2

object named as

Werner Poewe

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Wolfgang H. Oertel

1

object named as

Wolfgang Oertel

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

Erik Wolters

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Peter Paul De Deyn

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Murat Emre

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Courtney Kirsch

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Chuanchieh Hsu

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sibel Tekin

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Roger Lane

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

79-94

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Cholinergic dysfunction in diseases with Lewy bodies.

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200831010-00007

21 January 2018

Cholinergic-anticholinergic antagonism in parkinsonism.

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200831010-00007

21 January 2018

Progression of parkinsonian signs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200831010-00007

21 January 2018

Parkinsonian signs and cognitive function in old age.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent finding on dopaminergic transmission in the basal ganglia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional decline in Parkinson disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale for current therapies in Parkinson’s disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesterase

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationships between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease and normal elderly individuals.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivastigmine (Exelon) for dementia in patients with Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parkinson's disease: the thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurobiology of butyrylcholinesterase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinesterase inhibition in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathophysiology of parkinsonian tremor: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in motor subtype and risk for incident dementia in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathogenesis of Parkinson's disease: a new hypothesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivastigmine for dementia associated with Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parkinsonianlike Signs and Risk of Incident Alzheimer Disease in Older Persons

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional effects of antipsychotic drugs: comparing clozapine with haloperidol

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of motor impairment and disability in Parkinson disease: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parkinson's disease. First of two parts

1 reference

https://pubmed.ncbi.nlm.nih.gov/18095748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002018-200831010-00007

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42640493&oldid=2205570165"